RHPN1

RHPN1 (Rhophilin-1) is a RhoA-binding effector that modulates RhoA-dependent actin cytoskeletal remodeling in a context-dependent manner (PMID:12221077, PMID:25071083). It binds both GDP- and GTP-bound RhoA in vitro, indicating a nucleotide-independent interaction mode, and unlike Rhophilin-2 its overexpression alone does not reorganize actin stress fibers (PMID:12221077). In primary podocytes, RHPN1 localizes to the plasma membrane leading edge and dampens RhoA signaling: its loss elevates myosin regulatory light chain phosphorylation and drives actomyosin hypercontractility, foot process effacement, and glomerular filtration barrier failure, with concurrent RhoA deletion worsening injury and establishing RHPN1 as a negative modulator of RhoA-dependent contractility (PMID:25071083). RHPN1 also acts as a downstream effector in a RhoA–Rhophilin-1 cascade that suppresses KLF2 transcription in macrophage-like cells (PMID:19786564), and in triple-negative breast cancer cells it cooperates with ROPN1 to activate RhoA, promoting stress fiber assembly, migration, and invasion (PMID:32427399). Beyond these RhoA-coupled roles in cytoskeletal and transcriptional control, no further mechanistic detail has been characterized in the available corpus.

1. 2002 Medium

   Established that Rhophilin-1 is a RhoA-binding protein with a distinct mode and cellular consequence from its paralog, defining its biochemical relationship to RhoA.

   Evidence GST-capture pulldown with nucleotide-loaded RhoA plus overexpression and actin imaging in HeLa cells

   PMID:12221077

   Open questions at the time

   • Binding interface and structural basis of nucleotide-independent association not defined
   • Functional consequence of RhoA binding in vivo not addressed
   • No physiological cell context examined
2. 2009 Medium

   Placed RHPN1 in a RhoA effector cascade controlling gene expression, showing it acts downstream of RhoA to suppress KLF2 transcription.

   Evidence shRNA knockdown of RhoA and RHPN1 with qRT-PCR readout of KLF2 mRNA in macrophage-like cells

   PMID:19786564

   Open questions at the time

   • Molecular link between RHPN1 and KLF2 promoter regulation unknown
   • Single loss-of-function method without rescue
   • Direct versus indirect effect not distinguished
3. 2014 High

   Defined RHPN1's physiological role as a negative modulator of RhoA-dependent actomyosin contractility required for podocyte architecture and the glomerular filtration barrier.

   Evidence Rhpn1-null and RhoA conditional KO mice with phospho-MLC assays, immunofluorescence localization, electron microscopy, and genetic epistasis

   PMID:25071083

   Open questions at the time

   • Mechanism by which RHPN1 dampens RhoA output at the leading edge not resolved
   • Whether direct RhoA binding mediates the dampening untested
   • Generalizability beyond podocytes unclear
4. 2020 Medium

   Revealed a context where RHPN1 promotes rather than dampens RhoA signaling, acting with ROPN1 to drive stress fiber formation and tumor cell invasion.

   Evidence Gain- and loss-of-function of ROPN1/RHPN1 in TNBC lines with RhoA activity assays, actin imaging, and in vivo metastasis assays

   PMID:32427399

   Open questions at the time

   • Direct physical interaction between ROPN1 and RHPN1 not biochemically resolved
   • Basis for opposing RhoA effects across cell types unexplained
   • Structural mechanism of RhoA activation unknown

• How RHPN1 switches between dampening and activating RhoA-dependent cytoskeletal output across cell types remains unresolved.
• No structural model of the RHPN1–RhoA or RHPN1–ROPN1 interface
• No identified determinant of context-specific signaling polarity
• Mechanistic link to downstream MLC and KLF2 outputs incompletely mapped